AKBMO Stock Overview
Engages in harvesting krill and supplies krill-derived products worldwide. More details
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Aker BioMarine AS Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NOK 95.60 |
52 Week High | NOK 0 |
52 Week Low | NOK 0 |
Beta | 0.88 |
11 Month Change | 0% |
3 Month Change | 1.92% |
1 Year Change | n/a |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 41.73% |
Recent News & Updates
Recent updates
Shareholder Returns
AKBMO | GB Food | GB Market | |
---|---|---|---|
7D | 0% | 0.4% | 2.2% |
1Y | n/a | 5.2% | 8.0% |
Return vs Industry: Insufficient data to determine how AKBMO performed against the UK Food industry.
Return vs Market: Insufficient data to determine how AKBMO performed against the UK Market.
Price Volatility
AKBMO volatility | |
---|---|
AKBMO Average Weekly Movement | n/a |
Food Industry Average Movement | 3.8% |
Market Average Movement | 4.8% |
10% most volatile stocks in GB Market | 10.3% |
10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: AKBMO's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: Insufficient data to determine AKBMO's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2006 | 373 | Matts Johansen | www.akerbiomarine.com |
Aker BioMarine AS engages in harvesting krill and supplies krill-derived products worldwide. It operates through two segments, Ingredients and Brands. The Ingredients segment is involved in the offshore harvesting and production, logistical operations, and onshore manufacturing and sales of krill-derived products for nutraceutical, pet food, and aquaculture industries.
Aker BioMarine AS Fundamentals Summary
AKBMO fundamental statistics | |
---|---|
Market cap | NOK 4.34b |
Earnings (TTM) | -NOK 119.15m |
Revenue (TTM) | NOK 3.67b |
1.2x
P/S Ratio-36.4x
P/E RatioIs AKBMO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
AKBMO income statement (TTM) | |
---|---|
Revenue | US$338.40m |
Cost of Revenue | US$230.50m |
Gross Profit | US$107.90m |
Other Expenses | US$118.90m |
Earnings | -US$11.00m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 01, 2024
Earnings per share (EPS) | -0.13 |
Gross Margin | 31.89% |
Net Profit Margin | -3.25% |
Debt/Equity Ratio | 51.3% |
How did AKBMO perform over the long term?
See historical performance and comparison